Keywords: strong, data, gsk, lamictal, new, indication, uk

Strong data for GSK's Lamictal in new indication

Article | 07 August 2006

Print This

UK drug major GlaxoSmithKline has welcomed data published in the August 1 issue of Pediatrics showing that its drug Lamictal (lamotrigine) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in